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Unsafe abortionUnsafe abortion accounts for approximately 13% of maternal deaths worldwide—roughly 47000 deaths per
year. Most deaths from unsafe abortion occur in low-resource countries. Second-trimester abortion carries a
higher risk of morbidity and mortality compared with first-trimester abortion and, although the former
comprises the minority of abortion procedures worldwide, it is responsible for the majority of serious
complications and death where unsafe abortion is prevalent. Therefore, improving access to safe second-
trimester abortion must be a priority in low-income regions of the world if the majority of deaths from unsafe
abortion are to be prevented. In the present paper, we consider a variety of barriers to second-trimester care,
including healthcare provider training and abortion stigma, which may lead to neglect of unmet need for
second-trimester services.
© 2011 International Federation of Gynecology and Obstetrics. Published by Elsevier Ireland Ltd. All rights reserved.Unsafe abortion accounts for approximately 13% of maternal
deaths worldwide—roughly 47 000 deaths per year [1,2]. Of the
estimated 21.6 million unsafe abortions each year, 98% take place in
low-income countries—with the highest rates occurring in the lowest-
resource areas, where the case fatality ratio is approximately 218
deaths per 100 000 unsafe abortions [2]. By contrast, there are 0.7
deaths per 100 000 procedures in the USA [3]. Indeed, for many low-
income countries, it will be impossible to meet Millennium Develop-
ment Goal 5 (reducing maternal mortality by 75% by 2015) without
addressing preventable maternal deaths from unsafe abortion [4].
Complications associated with abortion (safe or unsafe) vary
according to the duration of a woman's pregnancy. Second-trimester
abortion carries a higher risk of morbidity and mortality than does
first-trimester abortion, even when performed under the best of
circumstances. In the USA, for example, abortion is exceedingly
safe; however, the relative risk of death from abortion performed
at 16–20 weeks of gestation is approximately 30 times that for a
procedure performed at 8 weeks or earlier, although it is still less than
one-quarter of the risk of death from carrying a pregnancy to term
[3,5]. Second-trimester abortion is even riskier when carried out by
persons lacking necessary skills or in an environment that does not
conform to minimal medical standards.
Worldwide, approximately 10% of abortions take place in the
second trimester but this figure may be as high as 25%–30% inand Gynecology, University of
l Center Drive, Ann Arbor, MI
s).
eration of Gynecology and ObstetricsIndia and South Africa [6–9]. Although second-trimester abortion
comprises the minority of abortion procedures, it may be respon-
sible for the majority of serious complications and death, especially
in settings in which unsafe abortion is prevalent. A retrospective
review of maternal deaths in Benin City, Nigeria, found that 59% of
abortion-related deaths occurred among women whose abortion
was induced in the second trimester [10]. A study from Russia [11]
reported that, although only 6.6% of all abortions took place in the
second trimester, 76% of abortion-related deaths were among
women who terminated their pregnancies in this period. Another
review of death records found that all recent abortion-related
deaths from a region in Mexico occurred in the second trimester
[12].
With this lens, second-trimester services become a crucial element
of abortion care everywhere. Arguably, one strategy to reduce the
need for second-trimester abortion would be to increase the
availability of first-trimester abortion. However, lack of access to
early care is not the only reason why women present in the second
trimester; risk factors for second-trimester abortion include late
recognition of pregnancy, adolescence, poverty and financial barriers,
substance addiction, lack of awareness of abortion laws, and changing
health or relationship status [13,14]. In addition, most countries
permit abortion when the life or health of the pregnant woman is
threatened or for serious fetal malformations—neither of which is
frequently encountered until the second trimester [15]. Efforts to
improve access to early termination have successfully moved more
abortions into the period before 9 weeks of gestation but the
incidence of abortions performed after 12 weeks remains unchanged
[6,7]. Therefore, it is unlikely that second-trimester abortion will
disappear. Indeed, longitudinal data from the USA and the UK show. Published by Elsevier Ireland Ltd. All rights reserved.
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all terminations [6,7].
Another strategy to reduce second-trimester abortion would be
to make it illegal. However, it is already very well known—through
natural experiments in Romania and elsewhere—that legal restriction
does not reduce abortion or permanently increase the birth rate; it
simply makes abortion procedures (at any duration of pregnancy)
more unsafe and increases maternal mortality [16,17]. Preliminary
evidence indicated that abortion-related complications in Nepal did
not immediately decrease after legalization in 2002, partly because of
the difficulty in accessing abortion care after 12 weeks of pregnancy
[18]. More research is needed documenting the public health impact
of restricting abortion access after the first trimester.
Both medical and surgical abortion methods can be used in the
second trimester. The combined mifepristone–misoprostol medical
regimen is significantly more effective and results in a shorter
time to abortion compared with misoprostol alone [19]. Surgical
second-trimester abortion is accomplished via dilation and evacua-
tion, whereby the fetus is removed in parts using surgical in-
struments. Dilation and evacuation is the only second-trimester
surgical method recommended by theWHO [20]. Limited randomized
controlled trial data and a Cochrane review indicate that it is superior
to induction, with fewer adverse effects, faster completion time, less
pain, and overall higher patient acceptability [21–23]. Conclusive data
are lacking on provider acceptability of dilation and evacuation versus
induction termination. Some doctors find dilation and evacuation
emotionally difficult; however, induction shifts the emotional burden
to the nurses who care for laboring patients [24].
In many countries, neither medical nor surgical second-trimester
abortion services are readily available, owing to, for example, real or
perceived legal barriers, lack of trained providers, and concentration
of the few existing services in urban centers [15]. Even where second-
trimester services are available, evidence regarding the safest and
most effective abortion procedures has not been widely translated
into practice. Extra-amniotic instillation of ethacridine lactate is used
in India [25], and hysterotomy is not infrequently performed for later
abortion when medical methods fail [26]. Ineffective misoprostol
regimens are used, often requiring hospitalization for several days
[26]. Mifepristone is rarely used in the second trimester, largely
because it is not available in many countries or because it is not
registered for such use if it is available. Although dilation and
evacuation has been successfully introduced in some areas of Nepal,
Vietnam, and South Africa [27,28], it is not widely available.
Why are safe second-trimester services scarce? And why is
dilation and evacuation not more widely adopted? One answer is
that dilation and evacuation requires a highly trained provider,
making its introduction less feasible in many low-resource settings
[29]. However, resources and training may be only a part of a
more complex picture. The visceral dimensions of second-trimester
abortion, and related abortion stigma, likely have important roles
as well [30].
Abortion is highly stigmatized around the world because of,
for example, belief that abortion is killing, disapproval of behaviors
perceived to have led to unintended pregnancy (i.e. sexual activity
or “irresponsible” use of contraception), and belief that abortion
represents deviation from feminine maternal ideals [31,32]. Because
of this stigmatization, most women do not speak freely about their
abortions, leading to the misperception that abortion is rare or
unusual—a “prevalence paradox,” as described by Kumar et al. [32].
This misperception leads to a vicious cycle of further stigma and
ongoing silence. In other words, stigma makes abortion unspeakable.
In the second trimester, the stigma surrounding abortion is
magnified. Women may have felt fetal movement or been “showing;”
furthermore, the second-trimester aborted fetus resembles a small
infant and—unlike in the first trimester—is no longer hidden in a mass
of placental and decidual tissue. Medical induction of labor feels andlooks like birth, except that the delivered fetus is dead or shows
transient signs of life. With dilation and evacuation, the fetus is
removed in parts, and providers must account for all parts before
declaring the procedure complete. Thus, one cannot neglect the
corporeality of the fetus in the second trimester. Stigma in this
trimester is, therefore, writ large: later abortion looksmore like killing
a born person; women may be derisively asked why they “waited so
long;” and women may be perceived as the ultimate anti-maternal
figure when they consent to the dismemberment of a recognizable
fetus.
We suggest that stigma regarding second-trimester abortion is so
intense that it takes the form of blindness toward—even denial of—the
need for such services. The very idea of second-trimester abortion is
so disturbing that it creates disbelief that any woman would ever
request such care or that any respectable doctor would ever perform
this particular kind of “dirty work.” Whereas stigma makes abortion
unspeakable in general, it makes abortion unthinkable in the second
trimester. Is it possible that blindness to unmet need, rooted in stigma,
explains, in part, why efforts to reducematernal mortality from unsafe
abortion in many regions of the world have not directly addressed
second-trimester abortion?
What can be done? To begin with, abortion care—including second-
trimester procedures—must be mainstreamed into pre-service training
for physicians and nurses everywhere. Access to safe and acceptable
medical induction could be greatly expanded by registering mifepris-
tone for this indication and making the drug widely available.
Clinicians can work to reduce delays by streamlining referrals for
abortion care. The “demand” aspect of the issue must also be addressed
by improving access to comprehensive sexuality education and to the
full range of effective contraceptive methods. Community education
about early recognition of pregnancy (including access to free or low-
cost pregnancy tests) and the importance of obtaining abortion as
early as possible when pregnancy is not desired must be provided.
And physicians and women's health advocates must work to reduce
abortion stigma because it likely contributes both to women's use of
unsafe clandestine services and to delays in seeking safe abortion care
when it is available.
Data on unmet need for later abortion are also required. Women's
outcomes are unknownwhen they are turned away from care because
of the duration of their pregnancy. These women may be at particular
risk for unsafe self-induced or clandestine abortion. National vital
statistics data may need to be refined to capture the incidence of
second-trimester abortion specifically, in addition to distinguishing
between morbidity/mortality from unsafe second-trimester abortion
and that from unsafe first-trimester abortion.
Every woman who decides to have an abortion should be able to do
so as early as possible in her pregnancy, when the procedure is safest
and easiest to perform. However, to reduce maternal morbidity and
mortality from unsafe abortion, a comprehensive vision of safe services
must encompass second-trimester abortion care. Even if, conservatively,
only half of abortion-related deaths occur in the second trimester,
focusing exclusively on improving first-trimester abortion care would
leave 23500 of 47000 deaths per year largely untouched. Healthcare
providers, women's health advocates, and health policy makers must
stop neglecting thatwhich theyfinddifficult, and provide the care that a
small—but significant—number of women need.
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